Clinical trial

Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in…

NCT00056056 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Terminated

Key facts

NCT number NCT00056056
Title Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides
Official title A Randomized, Open-Label Phase III Trial to Evaluate the Efficacy and Safety of Bexarotene (Targretin) Capsules Combined With PUVA, Compared to PUVA Treatment Alone in Patients With Mycosis Fungoides
Lead sponsor European Organisation for Research and Treatment of Cancer - EORTC, Other
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Lymphoma
Intervention type Drug, Procedure
Interventions bexarotene, methoxypsoralen, UV light therapy
Enrollment 93
Start date Jan 1, 2003
Primary completion May 1, 2010
Completion Jun 1, 2011
First posted Mar 7, 2003
Last update posted Jul 9, 2018
Countries Austria, Belgium, Denmark, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Spain, Switzerland and 1 more

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies